Medical Science Liaison

I am partnering with an innovative global biopharmaceutical company to resource a contract Medical Science Liaison role in Canada. This is a rare opportunity to help establish a new Canadian medical affairs presence in ultra-rare neurology and metabolic disease.

Our client is preparing for an anticipated Health Canada submission in early 2027, followed by launch preparation for a therapy in a rare neurological disease area. The MSL will play a foundational role in building scientific engagement and KOL relationships ahead of launch.

Location: Quebec - bilingual French/English (professional fluency required

Contract - 40 hrs a week

12 months

Job Description

• Build and lead scientific relationships with KOLs, rare disease centers, geneticists, pediatric neurologists, and patient-advocacy stakeholders across Quebec.
• Deliver credible, balanced scientific exchange in rare neurological and metabolic disease areas, including lysosomal storage disorders, inherited ataxias, and related conditions.
• Gather actionable clinical and research insights to inform medical strategy, evidence generation, and launch readiness.
• Support internal stakeholders on therapeutic-area strategy, congress planning, advisory boards, and field medical execution.
• Work home-based within Quebec with approximately 50% travel.

Job Requirements

• PharmD, PhD, or MD.
• Proven MSL experience in rare disease, ideally ultra-rare disease.
• Strong background in neurology, metabolic disease, or genetics; experience in lysosomal storage disorders, inherited ataxias, neuromuscular disease, ALS, or rare pediatric neurology is highly valued.
• Experience building KOL networks from zero, particularly across geneticists, pediatric neurologists, and rare disease treatment centers.
• Launch experience is strongly preferred, especially in Canada; familiarity with Health Canada, INESSS, CDA, and pCPA processes is an asset.